Vascular Biogenics Ltd. (VBLT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 9.31M |
| Enterprise Value | -7.79M |
| P/E Ratio | -0.05 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 7.72 |
| Price/Book Ratio | 0.04 |
| Enterprise/Revenue | -23.81 |
| Enterprise/EBITDA | 0.51 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | June 30, 2024 |
| Profit Margin | -36.34 |
| Operating Margin | -47.28 |
| Return On Assets | -0.58 |
| Return On Equity | -0.6 |
| Revenue | 658,000 |
| Revenue/Share | 0.14 |
| Gross Profit | 554,000 |
| EBITDA | -31.16M |
| Net Income | -32.22M |
| Diluted EPS | -0.42 |
| Total Cash | 4.09M |
| Total Cash/Share | 5.28 |
| Total Debt | 1.8M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 5.65 |
| Book Value Per Share | 6.75 |
| 52-Week Change | 19.72 |
| 52-Week High | 0.32 |
| 52-Week Low | 0.1 |
| Moving Average 50 Days | 0.23 |
| Moving Average 200 Days | 0.21 |
| Average Volume | 787,717 |
| Shares Outstanding | 77.64M |
| % Held by Institutions | 1.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | October 17, 2023 |